Wake Forest University Health Sciences
This is a prospective, non-randomized, interventional, dual site, before-after clinical trial to determine feasibility and safety of a single injection of autologous Adipose Derived (AD) Stromal Vascular Fraction (SVF) for the treatment of knee Post Traumatic Osteoarthritis (PTOA).
Osteoarthritis
Adipose Derived (AD) Stromal Vascular Fraction (SVF)
EARLY_PHASE1
Clinical treatment generally involves a life-long combination of exercise, lifestyle modifications, and/or analgesics. If pain becomes debilitating, different surgical options exist, including arthroscopic joint debridement and mechanical axis change through osteotomies around the knee and eventually joint replacement surgery for severe cases to improve the quality of life. However, patients under 40 years of age, who expect to continue an active lifestyle, have only a 40% "good or excellent" function score after total knee replacement, they are most likely to outlive their initial replacement and need revision.
Study Type : | INTERVENTIONAL |
Estimated Enrollment : | 10 participants |
Masking : | NONE |
Primary Purpose : | TREATMENT |
Official Title : | Pilot Trial of Intra-articular Stromal Vascular Fraction for the Treatment of Knee Post-Trauma Osteoarthritis and Biomarker Identification |
Actual Study Start Date : | 2024-10 |
Estimated Primary Completion Date : | 2025-06 |
Estimated Study Completion Date : | 2026-06 |
Information not available for Arms and Intervention/treatment
Ages Eligible for Study: | 18 Years to 45 Years |
Sexes Eligible for Study: | ALL |
Accepts Healthy Volunteers: |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
Not yet recruiting
Wake Forest University Health Sciences
Winston-Salem, North Carolina, United States, 27157